Lack of information, perceived necessity and awkwardness impact uptake of PrEP, study suggests
Can't see this email? View it online
   
  HIV/AIDS  
  The latest HIV/AIDS news from News Medical  
 Elton John welcomes expansion of opt-out testing for HIV to 46 Accident & Emergency sites across England and calls on all political leaders to do more to end AIDS in a speech at Speaker's HouseElton John welcomes expansion of opt-out testing for HIV to 46 Accident & Emergency sites across England and calls on all political leaders to do more to end AIDS in a speech at Speaker's House
 
Elton John was honored at a reception hosted by the All Party Parliamentary Group on HIV/AIDS at the Speaker's House today in recognition of his enduring commitment to ending the AIDS epidemic, both personally and through the work of the Elton John AIDS Foundation.
 
 
 Lack of information, perceived necessity and awkwardness impact uptake of PrEP, study suggestsLack of information, perceived necessity and awkwardness impact uptake of PrEP, study suggests
 
A new qualitative study from Bath psychologists suggests a lack of information and perceived necessity, as well as awkwardness, are impacting uptake of PrEP.
 
   Research shows how HIV drug could stop many coronavirus diseasesResearch shows how HIV drug could stop many coronavirus diseases
 
Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years.
 
   CRISPR-Cas9: Shaping the future of targeted drug developmentCRISPR-Cas9: Shaping the future of targeted drug development
 
The incorporation of CRISPR/Cas9 into clinical settings has promising applications for the future treatment of genetic disorders, human immunodeficiency virus (HIV) infection, and various malignant diseases.
 
   Major UK study finds high demand and efficacy for HIV PrEP among sexual health service attendeesMajor UK study finds high demand and efficacy for HIV PrEP among sexual health service attendees
 
HIV PrEP requirement, duration, uptake, and usage among sexual health services (SHS) attendees in England.
 
 Early treatment offers chance at medication-free remission for pediatric HIV patients
 
Early treatment offers chance at medication-free remission for pediatric HIV patientsAn unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.
 
 
 From surviving to thriving: a framework for long-term success in people with HIV
 
From surviving to thriving: a framework for long-term success in people with HIVNewsMedical spoke to Lisa Sterman, Global Executive Director, Global HIV Medical Affairs, Gilead Sciences, about the recently published LTS framework, recently highlighted at the opening ceremony of the 19th European AIDS Conference, which takes a person-centric approach to the HIV treatment journey.
 
 
 New early phase study evaluates “on-demand” HIV prevention method for women
 
New early phase study evaluates “on-demand” HIV prevention method for womenA fast-dissolving vaginal insert that women would use at or around the time of sex as an "on-demand" HIV prevention method is being evaluated in a new early phase study being conducted by MATRIX, a United States Agency for International Development (USAID)-funded project focused on the early research and development of innovative HIV prevention products for women.
 
 
 UKHSA report reveals continuous decline in HIV transmission but inequalities exist
 
UKHSA report reveals continuous decline in HIV transmission but inequalities existThe UK Health Security Agency (UKHSA) has published the latest evaluation report into the government's progress towards reducing HIV transmission.
 
 
 BU researcher wins NIH award to quantify long-term impact of nutritional interventions on TB incidence
 
BU researcher wins NIH award to quantify long-term impact of nutritional interventions on TB incidencePranay Sinha, MD, assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, has received a National Institutes of Health Mentored Research Scientist Development Award (K01).
 
 
 Closing the gender gap in HIV treatment could slash infection rates in Uganda
 
Closing the gender gap in HIV treatment could slash infection rates in UgandaA study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.
 
 
 Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patients
 
Canadian researchers aim to reduce chronic inflammation and comorbidities in HIV patientsTo mark the occasion of World AIDS Day, find out how Dr. Madeleine Durand and Andrés Finzi are working to reduce chronic inflammation and the risk of comorbidities in people living with HIV.
 
 
 Exploring the history behind ELISA
 
Exploring the history behind ELISAThis article explores enzyme-linked immunosorbent assays (ELISA) and their importance across many applications - from environmental and food contaminants to disease screening.
 
 
 Study highlights importance of HIV prevention for migrants in EU/EEA
 
Study highlights importance of HIV prevention for migrants in EU/EEAAcross the 30 countries of the European Union and European Economic Area (EU/EEA), 22,995 new HIV diagnoses were reported in 2022.